Financial Synergies Wealth Advisors, Inc. Jazz Pharmaceuticals PLC Transaction History

Financial Synergies Wealth Advisors, Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 12, 2024	SELL	$115.19 - $132.77 $460 - $531	-4 Reduced 40.0%	6 $723,000
Q4 2023 Apr 04, 2024	BUY	$114.26 - $136.0 $457 - $544	4 Added 66.67%	10 $1.59 Million
Q2 2023 Apr 04, 2024	SELL	$122.5 - $147.16 $490 - $588	-4 Reduced 40.0%	6 $744,000
Q4 2022 Apr 04, 2024	BUY	$129.72 - $159.85 $518 - $639	4 Added 66.67%	10 $1.59 Million
Q3 2022 Apr 04, 2024	SELL	$126.59 - $161.18 $506 - $644	-4 Reduced 40.0%	6 $800,000

Q2 2022 Apr 04, 2024	BUY	$141.59 - $168.66 $1,415 - $1,686	10 New	10 $1.56 Million

512

57.7M

65.9K

183K

Ticker JAZZ
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,680,700
Market Cap $6.99B
Description
Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...

Get notified when there are updates to the investment portfolio of Financial Synergies Wealth Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on Financial Synergies Wealth Advisors, Inc. with notifications on news.